首页> 外文期刊>The Lancet >Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
【24h】

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

机译:患有和不患有糖尿病的个体中肾脏疾病指标与死亡率和终末期肾脏疾病的关联:一项荟萃分析

获取原文
获取原文并翻译 | 示例
       

摘要

Background Chronic kidney disease is characterised by low estimated glomerular filtration rate (eGFR) and highalbuminuria, and is associated with adverse outcomes. Whether these risks are modified by diabetes is unknown.Methods We did a meta-analysis of studies selected according to Chronic Kidney Disease Prognosis Consortium criteria. Data transfer and analyses were done between March, 2011, and June, 2012. We used Cox proportional hazards models to estimate the hazard ratios (HR) of mortality and end-stage renal disease (ESRD) associated with eGFR and albuminuria in individuals with and without diabetes.Findings We analysed data for 1024977 participants (128 505 with diabetes) from 30 general population and high-risk cardiovascular cohorts and 13 chronic kidney disease cohorts. In the combined general population and high-risk cohorts with data for all-cause mortality, 75 306 deaths occurred during a mean follow-up of 8 " 5 years (SD 5-0). In the 23 studies with data for cardiovascular mortality, 21237 deaths occurred from cardiovascular disease during a mean follow-up of 9-2 years (SD 4-9). In the general and high-risk cohorts, mortality risks were 1-2-1-9 times higher for participants with diabetes than for those without diabetes across the ranges of eGFR and albumin-to-creatinine ratio (ACR). With fixed eGFR and ACR reference points in the diabetes and no diabetes groups, HR of mortality outcomes according to lower eGFR and higher ACR were much the same in participants with and without diabetes (eg, for all-cause mortality at eGFR 45 mL/min per 1 " 73 m2 [vs 95 mL/min per 1 " 73 m2], HR 1-35; 95% CI 1-18-1-55; vs 1-33; 1-19-1-48 and at ACR 30 mg/g [vs 5 mg/g], 1-50; 1-35-1-65 vs 1-52; 1-38-1-67). The overall interactions were not significant. We identified much the same findings for ESRD in the chronic kidney disease cohorts.
机译:背景慢性肾脏疾病的特征在于估计的肾小球滤过率低(eGFR)和白蛋白尿高,并与不良预后相关。这些风险是否会因糖尿病而改变尚不清楚。方法我们对根据慢性肾脏病预后协会标准选择的研究进行了荟萃分析。在2011年3月至2012年6月之间进行了数据传输和分析。我们使用Cox比例风险模型估算了患有eGFR和蛋白尿的个体的死亡率和终末期肾病(ESRD)的危险比(HR)。结果我们分析了来自30个普通人群和高危心血管队列和13个慢性肾脏疾病队列的1024977名参与者(患有糖尿病的128505名)的数据。在具有全因死亡率数据的普通人群和高危人群的总和中,平均8到5年(SD 5-0)随访期间发生了75306例死亡。在23项心血管疾病数据研究中,平均随访9-2年(SD 4-9),有21237人死于心血管疾病,在一般人群和高危人群中,糖尿病患者的死亡风险比糖尿病高1-2-1-9倍对于没有eGFR和白蛋白/肌酐比值(ACR)范围的无糖尿病患者,在糖尿病患者和无糖尿病组中具有固定eGFR和ACR参考点的糖尿病患者,根据较低eGFR和较高ACR得出的死亡率HR大致相同在患有和不患有糖尿病的参与者中(例如,因eGFR引起的全因死亡率,每1“ 73 m2为45 mL / min [vs每1” 73 m2为95 mL / min,HR 1-35; 95%CI 1-18- 1-55; vs 1-33; 1-19-1-48和ACR 30 mg / g [vs 5 mg / g],1-50; 1-35-1-65 vs 1-52; 1-38 -1-67)。总体交互作用不显着。在慢性肾脏病队列中,ESRD的发现几乎相同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号